Ossiam Amgen Inc Transaction History

Ossiam

$5.1 Billion
Q3 2024

A detailed history of Ossiam transactions in Amgen Inc stock. As of the latest transaction made, Ossiam holds 12,731 shares of AMGN stock, worth $3.36 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

12,731

Previous 205,672 93.81%

Holding current value

$3.36 Million

Previous $64.3 Million 93.62%

% of portfolio

0.08%

Previous 1.23%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $59.7 Million - $65.1 Million	-192,941 Reduced 93.81%	12,731 $4.1 Million
Q2 2024 Aug 13, 2024	BUY	$262.75 - $319.31 $41.1 Million - $49.9 Million	156,258 Added 316.22%	205,672 $64.3 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $8.06 Million - $9.73 Million	29,975 Added 154.2%	49,414 $14 Million
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $58.5 Million - $66 Million	-228,853 Reduced 92.17%	19,439 $5.6 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $4.35 Million - $5.4 Million	19,901 Added 8.71%	248,292 $66.7 Million
Q2 2023 Aug 11, 2023	BUY	$214.27 - $253.37 $39.6 Million - $46.9 Million	184,926 Added 425.46%	228,391 $50.7 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $2.95 Million - $3.59 Million	-13,047 Reduced 23.09%	43,465 $10.5 Million
Q4 2022 Feb 13, 2023	BUY	$229.03 - $291.01 $6.93 Million - $8.81 Million	30,266 Added 115.32%	56,512 $14.8 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $15.4 Million - $17.4 Million	-68,565 Reduced 72.32%	26,246 $5.92 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $4.15 Million - $4.61 Million	17,967 Added 23.38%	94,811 $23.1 Million
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $14.2 Million - $15.7 Million	64,825 Added 539.35%	76,844 $18.6 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $1.24 Million - $1.42 Million	6,250 Added 108.34%	12,019 $2.7 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $9.85 Million - $11.5 Million	-46,398 Reduced 88.94%	5,769 $1.23 Million
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $6.02 Million - $6.68 Million	25,788 Added 97.76%	52,167 $12.6 Million
Q1 2021 May 17, 2021	BUY	$221.91 - $258.6 $5.78 Million - $6.73 Million	26,031 Added 7480.17%	26,379 $6.56 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $1.5 Million - $1.79 Million	-6,942 Reduced 95.23%	348 $80,000
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $5.59 Million - $6.22 Million	-23,842 Reduced 76.58%	7,290 $1.85 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $6.11 Million - $7.5 Million	-30,910 Reduced 49.82%	31,132 $7.34 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $12.5 Million - $16.6 Million	-68,803 Reduced 52.58%	62,042 $12.6 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $24.7 Million - $31.7 Million	130,396 Added 29041.43%	130,845 $31.5 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $5,919 - $7,093	-34 Reduced 7.04%	449 $87,000
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $80,516 - $94,383	483 New	483 $89,000
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $448,195 - $505,214	-2,478 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $442,075 - $516,043	2,478 New	2,478 $482,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ossiam, based on Form 13F filings with the SEC.

News

Stay updated on Ossiam with notifications on news.

Account